Evidence map›Paper›PMID 34708726›Full record

ReviewIndian journal of ophthalmology2021

Epidemiology of type 2 diabetes in India.

Rajendra Pradeepa, Viswanathan Mohan

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 212 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
212citing papers in PubMed, 2 pooled it
48.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

212 citing papers in PubMed, 2 syntheses or guidelines pooled it, 532 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Narrative Review onEndocrine, metabolic & immune disorders drug targets · 2024
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Disparity in non-communicable disease burden attributable to ambient PMJournal of exposure science & environmental epidemiology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Review

152 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rajendra PradeepaMadras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, IDF Centre of Excellence in Diabetes Care and ICMR Centre for Advanced Research on Diabetes, Chennai, Tamil Nadu, India.
Viswanathan MohanMadras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, IDF Centre of Excellence in Diabetes Care and ICMR Centre for Advanced Research on Diabetes, Chennai, Tamil Nadu, India.
Dr. Mohan's Diabetes Specialities Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045. Approximately 57% of these individuals remain undiagnosed. Type 2 diabetes, which accounts for majority of the cases, can lead to multiorgan complications, broadly divided into microvascular and macrovascular complications. These complications are a significant cause for increased premature morbidity and mortality among individuals with diabetes, leading to reduced life expectancy and financial and other costs of diabetes leading to profound economic burden on the Indian health care system. The risk for diabetes is largely influence by ethnicity, age, obesity and physical inactivity, unhealthy diet, and behavioral habits in addition to genetics and family history. Good control of blood sugar blood pressure and blood lipid levels can prevent and/or delay the onset of diabetes complications. The prevention and management of diabetes and associated complications is a huge challenge in India due to several issues and barriers, including lack of multisectoral approach, surveillance data, awareness regarding diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, etc. Thus, effective health promotion and primary prevention, at both, individual and population levels are the need of the hour to curb the diabetes epidemic and reduce diabetes-related complications in India.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 2HumansIndiaLife StylePrevalenceRisk FactorsBurdencomplicationstype 2 diabetes

Identifiers

PMID34708726
PMCPMC8725109
OpenAlexW3210811841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.